Conceptus initiated with "buy"

06/14/07 - A.G. Edwards & Sons

NEW YORK, June 14 (newratings.com) - Analysts at AG Edwards initiate coverage of Conceptus Inc (CPTS) with a "buy" rating. The price objective is set to $24.

In a research note published this morning, the analysts mention that the company’s Essure device has gained substantial physician acceptance and is poised to become going forward a standard of care in the permanent female sterilization. There is strong brand recognition & physician loyalty for Essure and the device’s efficacy data has strengthened the company’s position in the transcervical sterilization device market, the analysts say.